<DOC>
	<DOCNO>NCT01768767</DOCNO>
	<brief_summary>This study look safety efficacy combine ketamine lithium therapy treat patient bipolar depression take mood stabilizer work .</brief_summary>
	<brief_title>Trial Ketamine Lithium Therapy Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Male female age 1865 year . Females include pregnant agree utilize medically accept birth control method ( include oral , injectable , implant birth control , condom , diaphragm spermicide , intrauterine device , tubal ligation , abstinence , partner vasectomy ) postmenopausal least 1 year , surgically sterile . Able provide write informed consent accord Yale HIC guideline . Bipolar Disorder Major Depressive Episode ( 296.5x 296.89 ) , determine Structured Clinical Interview DSMIV ( SCID ) patient edition 80 Montgomery Asberg Depression Rating Scale ( MADRS ) score 18 high . Quick Inventory Depressive Symptoms SelfReport ( QIDSSR16 ) score 19 high . Be able understand speak English . Patients history DSMIVTR diagnosis schizophrenia schizoaffective disorder currently exhibit psychotic feature associate depression . Patients current hypomanic and/or manic symptom meet DSMIVTR criterion mixed episode exclude . DSM IVTR Axis I disorder exclude consider primary disorder . Dementia suspicion thereof , also exclusionary . Serious suicide homicide risk , assess evaluate clinician ; A serious suicide risk consider inability control suicide attempt , imminent risk suicide investigator 's judgment , history serious suicidal behavior , define use ColumbiaSuicide Severity Rating Scale ( CSSRS ) either ( 1 ) one actual suicide attempt 3 year study entry lethality rat 3 high , ( 2 ) one interrupt suicide attempt potential lethality judge result serious injury death . Substance abuse dependence 3 month prior screen . History serious medical neurological illness . Signs major medical neurological illness examination result 12 lead ECG screen laboratory study . Abnormality physical examination . A subject clinical abnormality may include study physician considers abnormality introduce additional risk factor interfere study procedure . Positive urine drug screen . Pregnant lactate woman positive urine pregnancy test ; woman childbearing potential . Subjects test positive HIV viral hepatitis ( hepatitis B and/or C ) exclude mean ( 1 ) protect subject research staff increase risk blood borne pathogen transmission placebo/ketamine infusion ( 2 ) minimize factor might influence biochemical response affect study outcome . This test take place screen visit . Subjects invite back Yale Depression Research Program , either next study visit HIV/Hep debriefing session . HIV result give face face meeting matter result . Patients require excluded medication ( see Table 3 detail ) . History indicate learn disability mental retardation . Known sensitivity ketamine lithium . Resting blood pressure low 90/60 high 150/90 , rest heart rate lower 50/min high 100/min .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>